Ipamorelin vs. Sermorelin

When evaluating Ipamorelin versus Sermorelin for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.

When to prioritize Ipamorelin:

Select Ipamorelin when the primary clinical objective aligns with its core mechanism: selective ghrelin receptor (ghsr) agonist that stimulates pulsatile gh release with minimal effect on cortisol or prolactin.. This is particularly relevant for protocols focused on selective gh release with a favorable safety profile and minimal side effects..

When to prioritize Sermorelin:

Conversely, Sermorelin is the superior choice when targeting first 29 amino acids of endogenous ghrh that stimulates pituitary gh release through the ghrh receptor., making it the preferred agent for natural gh stimulation from the pituitary with a well-established safety record..